Centene Corp Del Stock Price, News & Analysis

Centene Corporation (NYSE: CNC) announced its Oklahoma subsidiary, Oklahoma Complete Health, has secured statewide contracts with the Oklahoma Health Care Authority to manage the SoonerSelect and SoonerSelect Specialty Children's Plan (SCP) programs. The SoonerSelect initiative will provide healthcare to over 550,000 Medicaid recipients, with an anticipated 200,000 more beneficiaries through Medicaid expansion in July 2021. The program aims to enhance health outcomes while reducing costs, emphasizing local partnerships and value-based care.

Health Net Federal Services, a subsidiary of Centene Corporation (NYSE: CNC), launched the Buckley Prime Service Area Pilot on January 1, 2021, in the Denver area. This initiative aims to transition TRICARE's fee-for-service model to a value-based payment approach, enhancing health outcomes and satisfaction for beneficiaries. Running until December 31, 2022, the pilot offers chronic care management, personalized services, and preventive care reminders. With approximately 2.9 million beneficiaries in the TRICARE West Region, this pilot aligns with the Military Health System's objectives for improved care and budget certainty.

Centene Corporation (NYSE: CNC) has launched the Centene Institute Youth Impact Award for Vaping Prevention, a program aimed at raising awareness about vaping among youth aged 14 to 19. The initiative encourages students to create 30-60 second PSAs addressing the risks of e-cigarette use, with submissions accepted from January 19 to April 16, 2021. The program comes in response to a significant increase in youth e-cigarette use, highlighted by a 900% rise from 2011 to 2018. Winners will be announced in early summer 2021, aiming to empower young individuals to combat the vaping epidemic.

Centene Corporation (NYSE: CNC) will announce its 2020 fourth quarter and full-year financial results on February 9, 2021, at 6 a.m. EST. A conference call will follow at 8:30 a.m. EST, hosted by Chairman and CEO Michael F. Neidorff and CFO Jeffrey A. Schwaneke. Investors can participate by phone or via a live audio webcast on the company's website. A replay of the call will be available for on-demand listening for the next 12 months. Centene is a leading healthcare company focused on providing affordable services to under-insured and uninsured individuals.

Health Net Federal Services, a subsidiary of Centene Corporation (CNC), announced its recent URAC accreditations in Health Utilization Management, Case Management, and Disease Management. This achievement underscores their commitment to quality care and improved patient outcomes. Health Net has maintained URAC's Health Utilization Management and Case Management accreditations since 2005, and Disease Management since 2011. These accreditations are valid through Dec. 1, 2023, for Health Utilization Management and Case Management, and through Oct. 1, 2023, for Disease Management.

Centene Corporation (CNC) and Magellan Health (MGLN) have announced a definitive merger agreement where Centene will acquire Magellan for $95 per share, totaling $2.2 billion. This strategic acquisition aims to enhance Centene's whole health capabilities and establish a leading behavioral health platform, expanding its reach to 41 million members and adding 5.5 million government-sponsored plan members. The transaction is expected to create shareholder value through improved services and synergies, with projected net cost synergies of $50 million by the second year.

Centene Corporation (NYSE: CNC) will present at the 39th Annual J.P. Morgan Healthcare Conference from January 11-14, 2021, in a virtual format. The presentation will take place on January 11 at 9:10 a.m. EST. Interested parties can access a live audio webcast via this link. A replay of the webcast will be available on Centene's website under the Investors section. Centene is committed to providing high-quality healthcare services to underserved populations.

Centene Corporation (NYSE: CNC) has announced the completion of its acquisition of PANTHERx, a leading specialty pharmacy focused on orphan drugs and rare diseases. This strategic move enhances Centene's pharmacy portfolio and emphasizes its commitment to delivering quality care for patients with complex health needs. PANTHERx will continue to operate independently under Centene's Envolve Pharmacy Solutions, which provides integrated services to millions in the U.S. The acquisition aims to strengthen Centene's position in the healthcare market while broadening access to essential medications.

Centene Corporation (NYSE: CNC) announced its financial guidance for 2021, projecting total revenues between $114.1 billion and $116.1 billion. Diluted EPS is expected to range from $3.82 to $4.06, and adjusted diluted EPS is forecasted at $5.00 to $5.30. The health benefits ratio is anticipated to be between 86.6% and 87.2%, with SG&A expense ratios of 8.8% to 9.3%. The 2020 revenue guidance remains confirmed at $109.8 billion to $111.4 billion, while diluted EPS guidance is updated to $3.08 to $3.18.